Treatment Information

Back

Liver Cancer treatment details. Chemotherapy, Biologic therapy.

Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Survival: monthsCountry:Germany
Toxiciy Grade:5City/State/Province:Düsseldorf
Treatments:Chemotherapy, Biologic therapyHospital:Heinrich-Heine-University Düsseldorf
Drugs:Journal:Link
Date:Nov 2014

Description:

Patients:
This phase 2 study involved 43 untreated hepatocellular carcinoma patients with an average age of 69 years; 86% were male.

Treatment:
Patients received chemotherapy with transarterial chemoembolization of doxorubicin and biologic therapy with sorafenib.

Toxicities:
Treatment-related deaths due to liver failure and multi-organ failure were reported. Grade 4 diarrhea and grade 3 hand-foot skin reaction, fatigue, and nausea were also reported.

Results:
The median overall survival was 20.1 months.

Support:
This study was supported by Bayer HealthCare.

Correspondence: Dr. Andreas Erhardt; email: [email protected]



Back